alzheimer - Nursing Case Study

Pathophysiology

• Primary mechanism: Accumulation of beta-amyloid plaques—misfolded proteins clump together outside neurons, disrupting cell communication and triggering inflammatory responses, leading to neuronal death.

• Secondary mechanism: Neurofibrillary tangles—abnormal tau protein accumulation inside neurons causes microtubule disintegration, impairing nutrient and waste transport, leading to cell death.

• Key complication: Progressive brain atrophy—loss of neurons and synapses in the cerebral cortex and certain subcortical regions results in cognitive decline and memory loss, affecting daily functioning and quality of life.

Patient Profile

Demographics:

78, female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Osteoarthritis

• Current medications: Donepezil, Metformin, Lisinopril, Acetaminophen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing memory loss and confusion

• Key symptoms: Difficulty with language, trouble recognizing familiar places, episodes of disorientation

• Vital signs: Blood pressure 150/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 170 mg/dL

Section 1

New Complications:

During a routine follow-up visit, the patient, a 78-year-old retired school teacher, presented with worsening symptoms that included increased episodes of disorientation, particularly in familiar environments, and a noticeable decline in her ability to perform activities of daily living. Her daughter, who accompanies her to appointments, reported that the patient had recently experienced a fall at home, resulting in minor bruises but no fractures. This incident raised concerns about her balance and safety, prompting further evaluation.

The healthcare team noted a decline in the patient's cognitive function, as evidenced by a decreased score on the Mini-Mental State Examination (MMSE), now showing moderate impairment consistent with Alzheimer's progression. Additionally, laboratory tests revealed a slight elevation in her HbA1c levels at 7.8%, indicating suboptimal control of her Type 2 Diabetes, which could be contributing to both her cognitive decline and increased cardiovascular risk. Given these findings, the team considered the potential complications of poor glycemic control and the risk of further falls due to cognitive and physical impairments.

To address these complications, the clinical team decided to adjust her diabetes management plan, potentially incorporating a newer antidiabetic medication with cognitive benefits. They also emphasized the importance of a home safety assessment to minimize fall risks, alongside exploring physical therapy options to improve balance and strength. These interventions aimed to improve her overall quality of life and slow the progression of her Alzheimer's symptoms, while rigorous monitoring of her blood pressure and glucose levels was advised to prevent further complications. The patient's daughter was actively involved in care planning, ensuring adherence to the new management strategies and enhancing support at home.

Section 2

Six weeks after the adjustments to her management plan, the patient returned for a follow-up visit. Her daughter reported some positive changes, particularly in the patient’s ability to recognize familiar faces and maintain a more stable mood, suggesting potential cognitive benefits from the new antidiabetic medication. However, despite these improvements, the patient experienced another fall, this time in the bathroom, resulting in a mild sprain of her left wrist. This incident highlighted persistent safety concerns and the need for further intervention.

During the visit, the healthcare team conducted a comprehensive assessment. The patient’s vital signs were stable, with blood pressure at 130/80 mmHg and a pulse of 72 beats per minute. Her HbA1c had decreased slightly to 7.3%, indicating improved glycemic control. Nonetheless, the patient still showed moderate impairment on the MMSE, with a score of 18 out of 30, reflecting ongoing cognitive challenges. A gait assessment revealed unsteady ambulation and difficulty with tandem walking, underscoring the necessity for intensified physical therapy to address balance issues.

The healthcare team decided to enhance the patient's fall prevention strategy. A referral for occupational therapy was made to modify the home environment further, focusing on bathroom safety adaptations. Additionally, the team discussed with the daughter the option of using assistive devices, such as grab bars and a walker, to improve her mother’s stability. The team planned a follow-up in four weeks to reassess the effectiveness of these interventions, ensuring that the patient’s safety and quality of life continued to be prioritized as part of her ongoing care plan.

Section 3

Four weeks later, the patient returned for her scheduled follow-up visit. The daughter reported that her mother was more adept at using the walker, which had been provided after the previous visit, and had experienced no further falls. However, new concerns emerged regarding the patient's increased disorientation and episodes of agitation, particularly in the late afternoon and early evening, suggestive of sundowning syndrome. This change in behavior prompted a re-evaluation of her current medication regimen and daily routine to identify potential triggers and optimize management strategies.

During the assessment, the patient's vital signs remained stable with a blood pressure of 128/78 mmHg and a pulse of 74 beats per minute. Despite these stable parameters, the patient's MMSE score had decreased slightly to 17 out of 30, indicating a marginal decline in cognitive function. Laboratory tests revealed a serum sodium level of 130 mEq/L, pointing to mild hyponatremia, which could potentially contribute to her confusion and agitation. The healthcare team suspected that the recent adjustments in her medication, particularly the addition of a diuretic for her hypertension, might be a contributing factor.

In response to these findings, the healthcare team decided to adjust the patient's medication by tapering the diuretic dose, with close monitoring of her serum electrolytes to prevent further hyponatremia. Additionally, they recommended the implementation of a structured daily routine with increased lighting in the afternoon and evening to help manage sundowning symptoms. A follow-up appointment was scheduled in three weeks to evaluate the effectiveness of these interventions and to reassess the patient's cognitive function and behavioral symptoms, ensuring a comprehensive approach to her evolving needs.

Section 4

Three weeks later, the patient returned for her follow-up appointment, accompanied by her daughter. The daughter reported some improvement in her mother's evening agitation since the implementation of a structured daily routine and increased lighting. However, she noted that her mother had started to exhibit signs of increased fatigue and occasional dizziness, particularly in the morning. The healthcare team conducted a thorough assessment to identify any new or ongoing complications.

During the assessment, the patient's vital signs were slightly altered, with a blood pressure reading of 110/70 mmHg and a pulse rate of 68 beats per minute. The slight hypotension raised concerns about the current medication regimen, particularly the ongoing tapering of the diuretic. Laboratory tests indicated that the patient's serum sodium level had improved to 134 mEq/L, suggesting a positive response to the adjusted diuretic dose. However, a new onset of mild anemia was detected, with a hemoglobin level of 11.0 g/dL, requiring further investigation.

The healthcare team suspected that the fatigue and dizziness could be linked to either the mild anemia or a drop in blood pressure. They decided to further adjust her antihypertensive regimen, potentially replacing the diuretic with a different class of medication to better balance her blood pressure without causing electrolyte imbalances. Additionally, nutritional counseling was provided to address the anemia, emphasizing iron-rich foods. A follow-up visit was scheduled in four weeks to closely monitor her blood pressure, cognitive function, and overall well-being, ensuring a comprehensive and responsive approach to her care.

Section 5

Four weeks later, the patient returned for her scheduled follow-up visit, again accompanied by her daughter. During the intervening weeks, the healthcare team had adjusted her medication regimen, replacing the diuretic with an ACE inhibitor to manage her blood pressure more effectively without exacerbating her electrolyte imbalances. At this appointment, the daughter reported that there had been some improvement in her mother's morning dizziness, though the fatigue persisted.

The initial assessment revealed that the patient's blood pressure had stabilized at 115/75 mmHg, and her pulse rate was consistent at 70 beats per minute. Her hemoglobin level was slightly improved at 11.5 g/dL, following the dietary adjustments recommended during the previous visit. Despite these positive developments, the healthcare team noted a new concern: the patient exhibited slight shortness of breath upon exertion, which was not present during prior assessments. Additionally, she had gained 3 kilograms since her last visit, raising concerns about potential fluid retention or heart function issues.

Given these findings, the team decided to conduct further diagnostic tests, including a chest X-ray and an echocardiogram, to evaluate her cardiac function and assess for possible congestive heart failure. The team also planned to monitor her iron levels more closely and consider iron supplementation if dietary changes alone proved insufficient. This proactive approach aimed to address her current symptoms while remaining vigilant for any emerging complications, ensuring that her complex health needs were met comprehensively. The healthcare team scheduled another follow-up appointment in two weeks to reassess her condition and review the results of the new diagnostic tests.